Lung Cancer Considered | Ouvir podcast online grátis

391 episódios

Patients, AI, and Lung Cancer: Finding Clarity in the Noise
19/05/2026 | 46min
In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Natalie Brown and Dr. Aurora Lucas to explore how patients and caregivers are using artificial intelligence in the context of lung cancer care. The discussion highlights real-world experiences, addressing both the benefits of AI in improving understanding and empowerment, and the risks of misinformation, overreliance, and lack of personalization. The conversation also offers practical guidance for patients, families, and clinicians on using AI responsibly while reinforcing the importance of partnership with the care team.

Guests:
Aurora Lucas, EdD
Lung Cancer Patient Advocate

Natalie S. Brown, MBA
Lung Cancer Advocate & Speaker
Founder, Beyond The Diagnosis LLC
LCC in Italian: Resectable EGFR-mutant NSCLC
08/05/2026 | 49min
As part of IASLC’s ongoing series of podcasts in world languages, Dr. Alfredo Addeo moderates a Virtual Tumor Board discussion with Dr. Andrea Fillipi and Dr. Piergiorgio Solli. The tumor board focuses on the management of resectable EGFR-mutant NSCLC.

Host: • Alfredo Addeo, MD
Head of Oncology Service
University Hospital Geneva

Guests:
Andrea R. Filippi, MD
Head of Radiation Oncology, Fondazione Istituto Nazionale dei Tumori, Milan
Associate Professor, Radiation Therapy
Department of Oncology, University of Milan

Piergiorgio Solli, MD, PhD
Head of Thoracic Surgery
IRCCS Fondazione Istituto Nazionale dei Tumori, Milan
LCC in Italian: Resectable EGFR-mutant NSCLC
08/05/2026 | 50min
As part of IASLC’s ongoing series of podcasts in world languages, Dr. Alfredo Addeo moderates a Virtual Tumor Board discussion with Dr. Andrea Fillipi and Dr. Piergiorgio Solli. The tumor board focuses on the management of resectable EGFR-mutant NSCLC.
Guest Name(s) & Title(s):

Host:
Alfredo Addeo, MD
Head of Oncology Service
University Hospital Geneva

Andrea R. Filippi, MD ([email protected])
Head of Radiation Oncology, Fondazione Istituto Nazionale dei Tumori, Milan
Associate Professor, Radiation Therapy
Department of Oncology, University of Milan
X: @AndrearicFili
LinkedIn: https://www.linkedin.com/in/andrea-r-filippi-94a459211/

Piergiorgio Solli, MD, PhD ([email protected])
Head of Thoracic Surgery
IRCCS Fondazione Istituto Nazionale dei Tumori, Milan
X: @PiergiorgioSoll
Instagram: https://www.instagram.com/sollipiergiorgio/
LinkedIn: https://www.linkedin.com/in/piergiorgio-solli-b1b85a73/
AACR 2026 Highlights: KRAS Updates
05/05/2026 | 46min
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses KRAS updates from the American Association for Cancer Research (AACR) 2026 Annual Meeting with Dr. Deborah Doroshow, Dr. David S. Hong, and Dr. Jonathan Riess.

Guests:

Deborah Doroshow, MD, PhD
Associate Professor of Medicine, Hematology/Oncology
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

David S. Hong, MD
Douglas E. Johnson Endowed Professor
Deputy Chair, Department of Investigational Cancer Therapeutics [A Phase I Program]
Division of Cancer Medicine
Clinical Medical Director, Clinical and Translational Research Center
The University of Texas MD Anderson Cancer Center

Jonathan Riess, MD
Associate Professor of Medicine, UC Davis Comprehensive Cancer Center
Director of Thoracic Oncology, University of California, Davis
LCC in Spanish: Manejo perioperatorio en cáncer de pulmón en estadio temprano
24/04/2026 | 48min
This episode of Lung Cancer Considered, part of IASLC’s World Language Series, features host Dr. Narjust Florez leading a Spanish-language discussion with Dr. José Corona-Cruz and Dr. Diego Carrillo on perioperative chemoimmunotherapy in early-stage lung cancer. Using a real-world case, they explore clinical decision-making, biomarker considerations, and surgical challenges, with a focus on implementation barriers in Latin America. The conversation highlights multidisciplinary strategies and practical insights to optimize care in resource-variable settings.

Mais podcasts de Ciência

Podcasts em tendência em Ciência

Sobre Lung Cancer Considered

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. Lung Cancer considered is funded in part by Current sponsors: • AbbVie • AstraZeneca • Gilead • J&J • Summit

Site de podcast

Ciência

Ouça Lung Cancer Considered, Naruhodo e muitos outros podcasts de todo o mundo com o aplicativo o radio.net

Obtenha o aplicativo gratuito radio.net

Guardar rádios e podcasts favoritos
Transmissão via Wi-Fi ou Bluetooth
Carplay & Android Audo compatìvel
E ainda mais funções

Abrir a app

Obtenha o aplicativo gratuito radio.net

Guardar rádios e podcasts favoritos
Transmissão via Wi-Fi ou Bluetooth
Carplay & Android Audo compatìvel
E ainda mais funções

Lung Cancer Considered

Leia o código,
baixe o aplicativo,
ouça.

Lung Cancer Considered: Podcast do grupo